In a new podcast, Anthony Feinstein discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis.
Listen here: bit.ly/3EPYLNE
Read the study: hubs.li/Q02366rr0
2023 is a year of milestones at The Lancet Group. We mark the anniversary of six of our journals, including #Lancet200, amongst other notable achievements.
Hear from Richard Horton and the Editors-in-Chief of your favourite Lancet journals as they share their recent highlights, a look forward at what’s to come in their fields, and their curated collection of impactful papers published in recent years: hubs.li/Q022gMf30
Every year, journals around the world receive different metrics to reflect their performance. While only a limited measure of our impact, we are pleased to share that The Lancet ranks:
#1 in general and internal medicine with an Impact Factor of 168·9
#2 in general medicine with a Scopus CiteScore of 133·2
Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continue publishing the best science for better lives.
You can access our full reach and impact statement for more information here: hubs.li/Q01WmrBC0
Health is a fundamental human right. Yet every year, 8.6 million avoidable deaths occur due to low-quality or underused care in low- and middle-income countries. “Whether we call it Universal Health Coverage or National Health Service, I want people to
Health is a fundamental human right. Yet every year, 8.6 million avoidable deaths occur due to low-quality or underused care in low- and middle-income countries.
“Whether we call it Universal Health Coverage or National Health Service, I want people to feel that it is something owed to them by the government”, says Ṣẹ̀yẹ Abímbọ́lá, Associate Professor of Public Health at Sydney University.
As part of The Lancet's 200th anniversary, we are shining a spotlight on the importance of achieving universal health coverage en route to health for all.
Listen to experts from around the world as they share insights and discuss their own efforts to advance health 👇 #Lancet200
We are now in our 200th year! 🎉 In 1823, Thomas Wakley founded The Lancet on the belief that advancing research and science should drive change for the greater good—a belief we maintain today. Over the next 12 months, The Lancet Group has bold plans
We are now in our 200th year! 🎉
In 1823, Thomas Wakley founded The Lancet on the belief that advancing research and science should drive change for the greater good—a belief we maintain today.
Over the next 12 months, The Lancet Group has bold plans to celebrate, self-reflect, and amplify our impact and vision.
And we want you to join us.
Find out more 👉 https://hubs.li/Q01x9bgV0 #Lancet200
2022 has been another exceptional year for The Lancet Group.
Register today to receive a bespoke email from the Lancet journals of your choice, containing insights from our editors and curated collections of influential papers published in recent years 👉 hubs.li/Q01pXnCX0
A heart of iron: juvenile haemochromatosis presents with cardiac failure. Dr Iside Cartella walks us through the case of a 39 y/o man in this Clinical Picture ⤵️
A heart of iron: juvenile haemochromatosis presents with cardiac failure.
Dr Iside Cartella walks us through the case of a 39-year-old man in this Clinical Picture ⤵️
A 32-year-old right-handed woman presented to a neurology clinic with a 3-month history of intermittent blurriness of her vision and left-sided paraesthesia in her arm and leg. The patient said that the problems began shortly after she gave birth to her
A 32-year-old right-handed woman presented to a neurology clinic with a 3-month history of intermittent blurriness of her vision and left-sided paraesthesia in her arm and leg.
The patient said that the problems began shortly after she gave birth to her first child and gradually became worse over the following 12 weeks.
In this video, Devin V Bageac describes what led to a diagnosis of cerebellar hemangioblastoma 👇
The Lancet Commission on the Value of Death
"Death is not just a physiological event, an endpoint—it's so much more than that."
Dying in the 21st century is a story of paradox, with some overtreated in hospitals as family and community are pushed to the margins, and others left to face death alone.
This is especially true in low-income countries, where suffering is rendered near-invisible in relation to the high-income countries that prioritise life-extending interventions, irrespective of the quality of that life.
Watch as Commissioners of the Lancet Commission on the Value of Death, Libby Sallnow and M R Rajagopal, propose a 'realistic utopia' for death and dying, showing us why society's relationship with death must be rebalanced ⬇️ hubs.li/Q014FQVW0
A 57-year-old native English-speaking man had a 5-week history of becoming unable to understand words—despite hearing them. He also reported a constant noise sounding "like trucks". What's going on? Dr Jacob M Pogson explains 👇
A 57-year-old native English-speaking man had a 5-week history of becoming unable to understand words—despite hearing them.
He also reported a constant noise sounding "like trucks".
What's going on? Dr Jacob M Pogson explains 👇
An accurate, timely diagnosis can be the difference between life and death—yet 47% of the 🌍 population has little or no access to diagnostics. A new Lancet Commission on diagnostics outlines recommendations to accelerate and transform access worldwid
An accurate, timely diagnosis can be the difference between life and death—yet 47% of the 🌍 population has little or no access to diagnostics.
A new Lancet Commission on diagnostics outlines recommendations to accelerate and transform access worldwide: hubs.li/H0YZX6B0
📺 Watch a new Clinical Picture. In this video, immunotactoid glomerulopathy (ITG) associated with monoclonal gammopathy. ITG is a rare glomerular disease encountered in 0.06% of native kidney biopsies; its management remains poorly defined. It is chara
📺 Watch a new Clinical Picture. In this video, immunotactoid glomerulopathy (ITG) associated with monoclonal gammopathy. ITG is a rare glomerular disease encountered in 0.06% of native kidney biopsies; its management remains poorly defined. It is characterised by electron microscopic findings of deposits comprising straight, long microtubules with hollow cores and a diameter of greater than 30nm.
Watch to learn more and read https://hubs.li/H0Phx5s0 for the full case.
Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica—Clinical Picture from Luis Rivas-Prado et al. Read the case in full: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00796-0/fulltext.
Hyperparathyroidism shows its hand: findings of osteitis fibrosa cystica—Clinical Picture from Luis Rivas-Prado et al. Read the case in full: https://hubs.ly/H0NVmJP0.
Clinical Picture—Pericardial effusion, cardiomegaly, oedema, and IgA deficiency in a child: coeliac disease. Read about the case: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00631-0/fulltext.
Clinical Picture—Pericardial effusion, cardiomegaly, oedema, and IgA deficiency in a child: coeliac disease.
Read about the case: https://hubs.li/H0LWJYn0.
Clinical Picture—Radiation pneumonitis and chemotherapy in a patient with multiple myeloma. Learn about the case by watching the video and reading https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00315-9/fulltext.
Clinical Picture—Radiation pneumonitis and chemotherapy in a patient with multiple myeloma. Learn about the case by watching the video and reading https://hubs.li/H0LqQQT0.
Clinical Picture—Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Read the full case here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00579-1/fulltext
Clinical Picture—Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
Read the full case here: https://hubs.li/H0Krn5L0
Lung transplantation is the only option for survival in some patients with severe, unresolving COVID-19-associated ARDS—and can be done successfully with good early post-transplantation outcomes. New research in The Lancet Respiratory Medicine by Ankit
Lung transplantation is the only option for survival in some patients with severe, unresolving COVID-19-associated ARDS—and can be done successfully with good early post-transplantation outcomes.
New research in The Lancet Respiratory Medicine by Ankit Bharat et al.: https://hubs.li/H0KnRtL0
📺 Clinical Picture—Metagenomic next-generation sequencing clinches diagnosis of leishmaniasis. Read the full case here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00352-4/fulltext
Clinical Picture—Metagenomic next-generation sequencing clinches diagnosis of leishmaniasis. Read the full case here: https://hubs.li/H0K1hb80
Clinical Picture—A mass in the mediastinum in a middle-aged man with fever, cough, and weight loss could be caused by many things. Melioidosis may masquerade as a malignancy and should be considered as a differential diagnosis. Read the case in full: ht
Clinical Picture—A mass in the mediastinum in a middle-aged man with fever, cough, and weight loss could be caused by many things. Melioidosis may masquerade as a malignancy and should be considered as a differential diagnosis.
Read the case in full: https://hubs.li/H0JDpYc0
🦻 1.5 billion people (1 in 5) were affected by hearing loss in 2019. This is projected to rise to 2.5 billion by 2050. Although most of those with a hearing impairment were over 50 years, 70 million children aged 0–15 years were also affected. Read f
🦻 1.5 billion people (1 in 5) were affected by hearing loss in 2019. This is projected to rise to 2.5 billion by 2050.
62% of those with a hearing impairment are over 50 years—but 70 million children aged 0–15 years are also affected. It is estimated 60% of hearing loss in children is preventable.
Read findings from the GBD study: Hearing loss prevalence and years lived with disability, 1990–2019. https://hubs.li/H0J9gYk0 Institute for Health Metrics and Evaluation (IHME)
